Compound Detail
CHEMBL629
AMITRIPTYLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL629 |
| Name | AMITRIPTYLINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | KRMDCWKBEZIMAB-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
55
Targets
155
Activities
4
Assay Types
19
PK Parameters
20
Publications
8
Known Names
20
Indications
Molecular Properties
277.4
MW (Da)
4.17
ALogP
1
HBA
0
HBD
3.2
PSA (Ų)
0.81
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1961 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Depressive Disorder Depressive Disorder Anxiety Cystitis, Interstitial Dementia Depressive Disorder, Major Fibromyalgia Headache Migraine Disorders Neuralgia Pain Schizophrenia Sleep Initiation and Maintenance Disorders Biliary Dyskinesia Bursitis Diabetes Mellitus Digestive System Diseases Inflammatory Bowel Diseases Intervertebral Disc Displacement Lung Diseases, Interstitial
ATC Classification
N06AA09
amitriptyline
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 99 meas. best 10.7
Ki 47 meas. best 9.26
Kd 6 meas. best 6.0
EC50 3 meas. best 4.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H1 receptor CHEMBL4701 | IC50 | 10.7 | 10.7 | 0.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 10.7 | 9.275 | 0.0 | 2 |
| Histamine H1 receptor CHEMBL231 | Ki | 9.26 | 9.105 | 0.6 | 2 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 9.13 | 9.13 | 0.7 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 9.05 | 8.1 | 0.9 | 6 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 8.78 | 7.52 | 1.7 | 2 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 8.56 | 8.56 | 2.7 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 8.5 | 8.5 | 3.2 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 8.43 | 8.43 | 3.7 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 8.36 | 8.36 | 4.4 | 1 |
| Histamine H1 receptor CHEMBL231 | IC50 | 8.32 | 8.32 | 4.8 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 8.28 | 8.28 | 5.3 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 8.27 | 8.27 | 5.4 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 8.25 | 8.25 | 5.6 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 8.24 | 8.24 | 5.8 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 8.22 | 8.22 | 6.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 8.09 | 8.09 | 8.1 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 8.07 | 8.07 | 8.6 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 7.82 | 7.82 | 15.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 7.66 | 7.07 | 22.0 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 7.64 | 6.665 | 23.0 | 2 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 7.54 | 7.54 | 29.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.39 | 5.86 | 41.0 | 7 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 7.38 | 7.38 | 42.0 | 1 |
| Serotonin (5-HT) receptor CHEMBL2094123 | IC50 | 7.36 | 7.36 | 44.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 7.35 | 7.35 | 45.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.28 | 6.01 | 53.0 | 7 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 7.28 | 7.28 | 52.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 7.23 | 7.23 | 59.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.21 | 6.95 | 62.0 | 2 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.21 | 5.5373 | 61.0 | 11 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 7.19 | 7.19 | 65.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 7.12 | 7.12 | 76.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 7.09 | 7.09 | 81.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 7.05 | 6.9 | 89.0 | 2 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 6.98 | 6.98 | 105.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.88 | 6.88 | 132.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 6.85 | 6.85 | 140.0 | 1 |
| D(1B) dopamine receptor CHEMBL1850 | Ki | 6.77 | 6.77 | 170.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 6.74 | 6.74 | 182.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.71 | 6.59 | 196.0 | 2 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 6.46 | 6.46 | 351.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | IC50 | 6.45 | 6.45 | 355.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.36 | 6.36 | 433.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 6.3 | 6.12 | 500.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 6.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.1 | mL.min-1.kg-1 | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| Fu | 0.06 | - | Homo sapiens |
| Fu | 0.07 | - | Homo sapiens |
| Fu | 0.07 | - | Homo sapiens |
| Fu | 0.09 | - | Rattus norvegicus |
| Fu | 0.01 | - | Rattus norvegicus |
| Fu | 0.009 | - | Rattus norvegicus |
| Fu | 0.0073 | - | Sus scrofa |
| Fu | 0.0083 | - | Rattus norvegicus |
| Fu | 0.0071 | - | Sus scrofa |
| MRT | 24.0 | hr | Homo sapiens |
| T1/2 | 27.5 | hr | - |
| T1/2 | 17.0 | hr | Homo sapiens |
| Vd | 15.0 | L.kg-1 | - |
| Vd | 310.0 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine